Pancreatic Cancer Research

ResearcherNew York UniversityNo recent work listed

Xin Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7414-5734; OpenAlex author ID A5100353939. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. The mycobiome-immune axis: The next frontier in pancreatic cancer. Co-author DOI 10.1016/j.ccell.2022.01.009↗
  2. The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Co-author DOI 10.1158/2159-8290.cd-17-1134↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Deepak Saxena · 1 shared paper, 2022 · strength 0.33
  2. Deirdre Jill Cohen · 1 shared paper, 2018 · strength 0.05
  3. Emma Kurz · 1 shared paper, 2018 · strength 0.05
  4. Donnele Daley · 1 shared paper, 2018 · strength 0.05
  5. Ryan B Sartor · 1 shared paper, 2018 · strength 0.05
  6. Deepak Saxena · 1 shared paper, 2018 · strength 0.05
  7. Smruti Pushalkar · 1 shared paper, 2018 · strength 0.05
  8. Berk Aykut · 1 shared paper, 2018 · strength 0.05
  9. Gregor Werba · 1 shared paper, 2018 · strength 0.05
  10. Constantinos Pantelis Zambirinis · 1 shared paper, 2018 · strength 0.05
  11. Alejandro Torres-Hernandez · 1 shared paper, 2018 · strength 0.05
  12. Brian E. Diskin · 1 shared paper, 2018 · strength 0.05
  13. George Miller · 1 shared paper, 2018 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.